Cedric O'Gorman Net Worth & Insider Trades

Cedric O'Gorman - Chief Medical Officer, Relmada Therapeutics, Inc

As of May 24, 2023

What is Cedric O'Gorman's Net Worth?

The current estimated net worth of Relmada Therapeutics, Inc's Chief Medical Officer, Cedric O'Gorman, is estimated to be about $34.51K . Cedric O'Gorman owns about 10,121 units of Relmada Therapeutics, Inc common stock. In the last 5 months at Relmada Therapeutics, Inc, Cedric O'Gorman has sold an estimated value of $0 worth.

What is Cedric O'Gorman's Past Insider Trading?

Cedric O'Gorman's largest purchase order was 10,000 units , worth over $31.8K on May 24, 2023. In total, Cedric O'Gorman has made about 2 transactions over 5 months of their time at Relmada Therapeutics, Inc. Cedric O'Gorman usually trades in January and May, with the busiest year in 2023.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Cedric O'Gorman

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Cedric O'Gorman's' Mailing Address?

  • Mailing address is C/o Relmada Therapeutics, Inc. 2222 Ponce de Leon Blvd, 3rd Floor Coral Gables FL 33134 FL

What are Relmada Therapeutics, Inc's Past Insider Trades?

Relmada Therapeutics, Inc's most recent insider trade came on May 24, 2023 by Cedric O'Gorman who bought 10,000 units worth $31.8K . In the last 8 years, insiders at Relmada Therapeutics, Inc have sold an estimated value of $13.8M and bought an estimated value of $4.2M worth of shares. Insider trading is most common in December, with the busiest year in 2021. The most active traders at the company are Charles J Casamento, Director,  Paul Kelly, Director,  and Sergio Traversa, Chief Executive Officer .

RELMADA THERAPEUTICS, INC. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...